BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2022
View Archived Issues
Cocktail of two human survivor antibodies protects NHPs from Ebola and Sudan virus diseases
Read More
Shanghai Hongheng Biomedical Technology divulges anticancer compounds
Read More
Janssen describes new Casein kinase I isoform delta inhibitors
Read More
New N-myristoyltransferase inhibitors presented by MyricX Pharma, Imperial Innovations Group
Read More
Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants
Read More
Phytos identifies new PD-L1 inhibitors
Read More
BCAT deletion from T cells may offer advantage to lymphoma immunotherapy
Read More
Inhibition of kininase I prevents angiotensin II-induced hypertension
Read More
IMP-2 validated as cancer target, small-molecule inhibitors identified
Read More
Targeting 5-HT1AR as novel therapeutic strategy for Fragile X syndrome
Read More
TLR9 inhibitor-loaded nanoparticles protect against radiation-induced BBB disruption
Read More
New small molecules synergize with ciprofloxacin against S. tiphy biofilms in the gallbladder
Read More
E-7011, a neutralizing antibody targeting Notch4 to inhibit tumor growth
Read More
Changes in the adaptive immunity of PD mice models carrying LRRK2 mutations drive neurodegeneration
Read More
Artiva and Merck & Co. agree to evaluate combinations of NK cells with trispecific NK-cell engagers
Read More
MJFF grant supports use of Lucy Therapeutics' mitochondrial platform to target Parkinson's disease
Read More
New approach enables systematic search for elusive allosteric binding sites on proteins
Read More
Captor's CT-01 compounds for HCC shown to induce degradation of GSPT1 and SALL4
Read More
Seed financing supports PolyCore's development of PCT-3012 for Parkinson's disease
Read More
SciRhom nominates anti-iRhom2 antibody as drug candidate for autoimmune diseases
Read More
BRD4-MK2 axis induces fibrosis in Crohn's disease
Read More
AAHI receives donation to support development of next-generation vaccine and therapeutic solutions
Read More